Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,603.3891 |
Reported balance
After 2026-05-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 7,182 · Balance 24,603.3891 F1: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. F2: Includes deferred stock units and dividend equivalent units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
F2: Includes deferred stock units and dividend equivalent units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2026 Filed May 8, 2026 20:15 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 7,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-214658 · ownership.xml · nonDerivative · entry 1 Kava Joseph Daniel · CIK 0002051800 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,603.3891 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board. F2 · balance_after: Includes deferred stock units and dividend equivalent units. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 21:27 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 14,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-007921 · form4.xml · nonDerivative · entry 1 Kava Joseph Daniel · CIK 0002051800 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,982 F1 · shares: Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the board. F2 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 01:27 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 2,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004717 · form4.xml · nonDerivative · entry 1 Kava Joseph Daniel · CIK 0002051800 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,886 F1 · shares: Represents restricted stock units that will convert on a one-for-one basis to Issuer common stock upon separation from service on the board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.